Annualized, that's roughly $3,576$13,788/year depending on which medication and pricing tier you land on
Receptor-specific binding probability analysis demonstrated high performance across all targets, with mean binding probabilities greater than 0.6 for GCGR and GLP1R, and approximately 0.53 for GIPR among the best-performing sequences (Figure 7C)
Additionally, patients with a history of bariatric surgery may already carry elevated hepatobiliary risk
However, it's also important to be aware that if the medication is stopped, this food noise can return, sometimes intensely
Next up -- we need to start testing carnitine in the context of the ketogenic diet
In plain terms, it works more like a timed release that depends on your metabolism than a switch that flips on quickly